Cargando…
Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib
Background: Disease-free survival (DFS) did not reflect accurate individual prognosis after initial diagnosis. As conditional DFS (CDFS) could provide dynamic prognostic information, we evaluated CDFS in these patients treated with or without sunitinib. Results: A total of 1329 patients with median...
Autores principales: | Shao, Ning, Su, Hengchuan, Ye, Dingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932878/ https://www.ncbi.nlm.nih.gov/pubmed/31825895 http://dx.doi.org/10.18632/aging.102549 |
Ejemplares similares
-
Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab
por: Shao, Ning, et al.
Publicado: (2019) -
Causes of Death and Conditional Survival of Renal Cell Carcinoma
por: Shao, Ning, et al.
Publicado: (2019) -
Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
por: Buda-Nowak, Anna, et al.
Publicado: (2017) -
Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016) -
Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)